Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
CytoSen Therapeutics and KBI Biopharma Enter into Strategic Partnership to Manufacture NK Cells and Nanoparticles
Wednesday, October 03, 2018CytoSen Therapeutics and KBI Biopharma today announced a strategic partnership to manufacture therapeutic Natural Killer NK cells using a proprietary and scalable closed system manufacturing process As part of the initial collaboration KBI will manuf...
Innovent Receives an Approval from the US FDA to Initiate Clinical Trials for its Anti-CD47 Monoclonal Antibody IBI-188
Monday, October 01, 2018Innovent Biologics Inc Innovent a worldclass Chinabased biopharmaceutical company that develops high quality drugs announced yesterday that its IND application for IBI a fully human antiCD monoclonal antibody mAb drug candidate has been approved by t...
FDA Approves Genentech's Xolair (Omalizumab) Prefilled Syringe Formulation
Monday, October 01, 2018Genentech a member of the Roche Group announced today that the US Food and Drug Administration FDA has approved mg mL and mg mL singledose prefilled syringes PFS for Xolair omalizumab as an additional formulation for both allergic asthma and chroni...
Enesi Pharma and Public Health England Enter R&D Collaboration for Novel Needle-Free Solid-Dose Vaccine for Emergent Threat Pathogens
Monday, October 01, 2018Enesi Pharma an innovative pharmaceutical company developing unique injectable solid dose vaccine products announces it has entered a research and development collaboration with Public Health England PHE an executive agency of the UK Governments Depa...
Dova Pharmaceuticals and Salix Enter Into Exclusive Co-Promotion Agreement For DOPTELET® (Avatrombopag)
Friday, September 28, 2018Dova Pharmaceuticals Inc a specialty pharmaceutical company focused on acquiring developing and commercializing drug candidates for diseases where there is a high unmet need and Salix Pharmaceuticals Salix one of the largest specialty pharmaceutical...
Cellular Biomedicine Group Enters Into Strategic Licensing and Collaboration Agreement with a Global Leader in CAR-T Cell Therapy for Patients in China
Friday, September 28, 2018Cellular Biomedicine Group Inc today announced it has entered into a strategic licensing and collaboration agreement with Novartis to manufacture and supply the CART cell therapy Kymriah tisagenlecleucel in China Novartis will be the exclusive holder...
Alexion to Acquire Syntimmune
Thursday, September 27, 2018Alexion Pharmaceuticals Incand Syntimmune today announced that they have entered into a definitive agreement for Alexion to acquire Syntimmune a clinicalstage biotechnology company developing antibody therapeutics targeting the neonatal Fc receptor F...
Selexis SA and Hoba Therapeutics Team Up to Advance Hoba’s Investigational Neuropathic Pain Treatment into the Clinic
Thursday, September 27, 2018Selexis SA and Hoba Therapeutics announced today that they have entered into an agreement to advance the development of Hobas clinical candidate HB rhMeteorin for the treatment of peripheral neuropathic pain Under the agreement Selexis is leveraging...
Tris Pharma Expands ADHD Portfolio with Acquisition of NextWave Pharmaceuticals
Wednesday, September 26, 2018Tris Pharma Inc Tris a pharmaceutical company focused on developing innovative technologybased therapeutic products that address unmet patient needs today announced the acquisition of NextWave Pharmaceuticals NextWave a wholly owned subsidiary of Pfi...
PeptiDream Announces Drug Discovery and Development Agreement with Santen Pharmaceutical
Wednesday, September 26, 2018PeptiDream Inc a public Kanagawabased biopharmaceutical company announced today that it has entered into a broadbased multitarget discovery and development agreement with Osakabased Santen Pharmaceuticals Co Ltd Santen Under the agreement PeptiDream...
